NASDAQ:DFNS Nukkleus (DFNS) Stock Price, News & Analysis $12.19 0.00 (0.00%) As of 08/28/2026 04:00 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOwnershipSEC Filings About Nukkleus Stock (NASDAQ:DFNS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Nukkleus alerts:Sign Up Key Stats Today's Range$11.90▼$12.5850-Day Range$3.90▼$84.9852-Week Range$3.70▼$1,948.75Volume577,571 shsAverage Volume2.23 million shsMarket Capitalization$12.31 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingModerate Buy Company Overview Nukkleus Inc., a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors. In addition, the company provides software, technology, customer sales and marketing, and risk management technology hardware and software solutions. Nukkleus Inc. was founded in 2013 and is headquartered in Jersey City, New Jersey. Read More Nukkleus Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks24th Percentile Overall ScoreDFNS MarketRank™: Nukkleus scored higher than 24% of companies evaluated by MarketBeat, and ranked 579th out of 671 stocks in the industrials sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.7 / 5Analyst RatingModerate Buy Consensus RatingNukkleus has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 strong buy rating, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageNukkleus has only been the subject of 2 research reports in the past 90 days.Read more about Nukkleus' stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthDecreasing Earnings GrowthEarnings for Nukkleus are expected to decrease in the coming year, from ($3.90) to ($5.09) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Nukkleus is -0.03, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Nukkleus is -0.03, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted16.11% of the float of Nukkleus has been sold short.Short Interest Ratio / Days to CoverNukkleus has a short interest ratio ("days to cover") of 0.06, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Nukkleus has recently decreased by 48.23%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldNukkleus does not currently pay a dividend.Dividend GrowthNukkleus does not have a long track record of dividend growth. News and Social Media2.9 / 5News Sentiment0.59 News SentimentNukkleus has a news sentiment score of 0.59. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.85 average news sentiment score of Industrials companies.News Coverage This WeekMarketBeat has tracked 13 news articles for Nukkleus this week, compared to 3 articles on an average week.Search InterestOnly 20 people have searched for DFNS on MarketBeat in the last 30 days. This is a decrease of -26% compared to the previous 30 days.MarketBeat Follows5 people have added Nukkleus to their MarketBeat watchlist in the last 30 days. This is an increase of 400% compared to the previous 30 days. Company Ownership0.5 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Nukkleus insiders have not sold or bought any company stock.Percentage Held by Insiders11.14% of the stock of Nukkleus is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions12.47% of the stock of Nukkleus is held by institutions.Read more about Nukkleus' insider trading history. Receive DFNS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nukkleus and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. DFNS Stock News HeadlinesNukkleus (NASDAQ:DFNS) & VirTra (NASDAQ:VTSI) Critical AnalysisAugust 29 at 4:02 AM | americanbankingnews.comWhat is Noble Financial's Forecast for Nukkleus Q3 Earnings?August 29 at 1:13 AM | americanbankingnews.comTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Trump has issued emergency support to accelerate the rollout, and it's already live in multiple states. The Financial Times reports Sam Altman is personally calling people to build this for OpenAI. A few little-known companies control the entire supply chain - meaning anyone who wants access must go through them. Their stocks are available to buy right now. | Altimetry (Ad)T3 Defense Subsidiary Tiltan to Deliver Majestic.ai as Licensed SoftwareAugust 26, 2026 | globenewswire.comWall Street Zen Upgrades Nukkleus (NASDAQ:DFNS) to SellAugust 23, 2026 | americanbankingnews.comT3 Defense Enters the UAV and Counter-UAV (C-UAV) Platform MarketAugust 21, 2026 | globenewswire.comT3 Defense Subsidiary Tiltan Receives Purchase Order from Leading Israeli Defense Contractor for Next-Generation Infrared Electro-Optical Simulation ProgramAugust 4, 2026 | globenewswire.comT3 Defense Inc. Subsidiaries Rimon and Tiltan Deliver Strong Year-to-Date Operating PerformanceJuly 31, 2026 | globenewswire.comSee More Headlines DFNS Stock Analysis - Frequently Asked Questions How have DFNS shares performed this year? Nukkleus' stock was trading at $503.75 on January 1st, 2026. Since then, DFNS stock has decreased by 97.6% and is now trading at $12.19. How were Nukkleus' earnings last quarter? Nukkleus Inc. (NASDAQ:DFNS) announced its earnings results on Wednesday, August, 19th. The company reported ($173.80) EPS for the quarter, missing the consensus estimate of ($3.11) by $170.69. The company had revenue of $4 million for the quarter, compared to analysts' expectations of $4.50 million. When did Nukkleus' stock split? Nukkleus shares reverse split on Thursday, October 24th 2024.The 1-8 reverse split was announced on Friday, October 18th 2024. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, October 23rd 2024. An investor that had 100 shares of stock prior to the reverse split would have 13 shares after the split. How do I buy shares of Nukkleus? Shares of DFNS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Nukkleus own? Based on aggregate information from My MarketBeat watchlists, some other companies that Nukkleus investors own include Lithium Americas (LAC), Meta Platforms (META), Advanced Micro Devices (AMD), iSpecimen (ISPC), NVIDIA (NVDA) and Applied Materials (AMAT). Company Calendar Last Earnings8/19/2026Today8/30/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorIndustrials Industry Aerospace & Defense Sub-IndustryAerospace & Defense Current SymbolNASDAQ:DFNS Previous SymbolNASDAQ:NUKK CIK1787518 Webwww.nukk.com Phone212-791-4663FaxN/AEmployees12Year Founded2013Profitability EPS (Trailing Twelve Months)($397.10) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$78.55 million Net MarginsN/A Pretax Margin-1,854.62% Return on Equity-190.60% Return on Assets-26.92% Debt Debt-to-Equity Ratio0.07 Current Ratio0.14 Quick Ratio0.11 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash Flow$406.33 per share Price / Cash Flow0.03 Book Value($90.93) per share Price / Book-0.13Miscellaneous Outstanding Shares1,010,000Free Float1,479,000Market Cap$12.31 million OptionableN/A Beta-5.80 Social Links 7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.Get This Free Report This page (NASDAQ:DFNS) was last updated on 8/31/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nukkleus Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nukkleus With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.